A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

NCT00002334 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89

NCT00002141 ·Status: COMPLETED ·Phase: PHASE1

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

NCT00299897 ·Status: UNKNOWN ·Phase: PHASE2

A Study of CI-1012 in HIV-Infected Patients

NCT00002196 ·Status: COMPLETED ·Phase: PHASE1

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

NCT00000760 ·Status: COMPLETED ·Phase: PHASE1

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

NCT00002311 ·Status: COMPLETED ·Phase: PHASE1

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

NCT00002035 ·Status: COMPLETED ·Phase: NA

A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects

NCT00397566 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

NCT00016692 ·Status: TERMINATED ·Phase: PHASE1

A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine

NCT00002333 ·Status: COMPLETED ·Phase: PHASE2

Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis

NCT00659971 ·Status: COMPLETED ·Phase: PHASE2

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

NCT00187512 ·Status: RECRUITING

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

NCT00495677 ·Status: COMPLETED ·Phase: PHASE2

SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

NCT00052897 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center

NCT01881971 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of Zidovudine in HIV-Infected Patients With Liver Disease

NCT00001001 ·Status: COMPLETED ·Phase: NA

The Safety and Effectiveness of 524W91

NCT00002335 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors

NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

NCT00002117 ·Status: COMPLETED ·Phase: PHASE3

A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NCT00000994 ·Status: COMPLETED ·Phase: PHASE3

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

NCT00002097 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

NCT04334915 ·Status: WITHDRAWN ·Phase: PHASE2

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

NCT00000823 ·Status: COMPLETED ·Phase: PHASE2

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)

NCT00002060 ·Status: COMPLETED ·Phase: NA